InsiderClue
Stocks · Financials · Blank Checks

Drugs Made In America Acquisition II Corp.

DMII Clue Score59
United States Fiscal year ends December CIK 0002040475
$10.19 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $10.19 +2.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Dec 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2025Operating income−0.5Net income4.2
FY2025
Operating income −0.5
Net income 4.2
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2025Operating cash flow−1.0
FY2025
Operating cash flow −1.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2025Cash0.0Shareholders’ equity−17.8
FY2025
Cash 0.0
Shareholders’ equity −17.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2025 31 Dec 2025
Revenue and profit
0.5
−0.5
Growth
4.2
Growth

Five years in brief

Worked out from the figures above, not from a press release
  • Profitable in every one of the 1 years on file.